Shuyang Zhang to Pandemics
This is a "connection" page, showing publications Shuyang Zhang has written about Pandemics.
Connection Strength
0.065
-
IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19. Mol Med. 2020 10 29; 26(1):97.
Score: 0.008
-
Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study. Sci Rep. 2020 10 16; 10(1):17524.
Score: 0.008
-
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Jun; 22(6):941-956.
Score: 0.007
-
Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU. Clin Chim Acta. 2020 Nov; 510:47-53.
Score: 0.007
-
Mendelian randomization in COVID-19: Applications for cardiovascular comorbidities and beyond. EBioMedicine. 2020 Jul; 57:102847.
Score: 0.007
-
Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak. Eur Heart J. 2020 05 14; 41(19):1791-1794.
Score: 0.007
-
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020 04 23; 382(17):e38.
Score: 0.007
-
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020 05; 214:108393.
Score: 0.007
-
Safety and efficacy of tracheotomy for critically ill patients with coronavirus disease 2019 (COVID-19) in Wuhan: a case series of 14 patients. Eur J Cardiothorac Surg. 2020 Oct 01; 58(4):745-751.
Score: 0.002
-
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort. J Am Soc Nephrol. 2020 09; 31(9):2205-2221.
Score: 0.002
-
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Clin Immunol. 2020 05; 214:108408.
Score: 0.002